16th Mar 2006 10:48
Henderson Morley PLC16 March 2006 FOR IMMEDIATE RELEASE 16 March 2006 HENDERSON MORLEY PLC (AIM) STATEMENT ON SHARE PRICE MOVEMENT The Board of Henderson Morley plc ("Henderson Morley" or "the Company"), notesthe movement in the Company's share price this morning, and press comment todaythat the Company has "agreed a multi-million pound deal with a majorpharmaceuticals group". The Company is able to confirm that it is in an advanced stage of contractualnegotiations with a potential partner to licence certain applications of itsIonic Contra Viral Therapy ("ICVT") technology, however no agreement has as yetbeen formally agreed. The Company is able to confirm that, if an agreement issigned, it is likely to involve the Company receiving a series of milestone,development and commercialisation payments during the period of productdevelopment and, ultimately, royalty payments based on sales of the productsderived from using the ICVT technology. The Company will make a further announcement as and when appropriate. --ENDS-- Copies of this announcement will be available free of charge to the public atthe Company's registered office at Metropolitan House, 2 Salisbury Road,Moseley, Birmingham, B13 8JS and at the offices of Brewin Dolphin SecuritiesLtd, 34 Lisbon Street, Leeds LS1 4LX for 14 days. Enquiries: HENDERSON MORLEY PLC Tel: 0121 442 4600Andrew Knight, Chairman BREWIN DOLPHIN SECURITIES LTD Tel: 0113 241 0126Neil Baldwin BISHOPSGATE COMMUNICATIONS LTD Tel: 020 7430 1600Maxine Barnes Mobile 07860 489571Dominic Barretto This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
HML.L